Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasogen -- Ignore unavailable to you. Want to Upgrade?

To: caly who wrote (17)	10/21/2003 7:09:38 AM
From: Tom Drolet	Read Replies (1) \| Respond to of 58

calypso: The filing of the Prospectus took a few out and the price down. A good decision to go with treasury shares vs private placements in the future. A bad sign that they are indicating that they will need more cash over and above the 70 Million in their reserves right now. (assumption by most was the last Private Placement would be enough to get them through to cash flow on their leading 2 Phase III trial therapies). That said--the timing is right to do it if you had too. The earlier the better--never close to a low cash position. I listened to Q 3 webcast--nothing particularly new. The yawn phase is upon us. Hoping for a bit more of a dip today before aquiring again. Doubled up on THY.TO yesterday--and looking at doubling CMT.TO if price continues down with this warm spell in Canada's east (60 degrees in Toronto today). Lost the football pool (again) at my son's workplace--I will have to study the stats better--or the young whipper snappers will throw me out! Best wishes Tom D.